300 related articles for article (PubMed ID: 11381190)
1. Biochemical changes in patients with combined chronic schistosomiasis and viral hepatitis C infections.
Fahim FA; Esmat AY; Hassan GK; Abdel-Bary A
Dis Markers; 2000; 16(3-4):111-8. PubMed ID: 11381190
[TBL] [Abstract][Full Text] [Related]
2. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
[TBL] [Abstract][Full Text] [Related]
3. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.
Ursu LD; Calenic B; Diculescu M; Dima A; Stoian IT; Constantinescu I
Int J Immunogenet; 2021 Feb; 48(1):16-24. PubMed ID: 32961633
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
5. The liver profile in patients with hepatitis C virus and/or fascioliasis.
Wahib AA; el-Nasr MS; Mangoud AM; el-Shazly AM; Morsy AT
J Egypt Soc Parasitol; 2006 Aug; 36(2):405-40. PubMed ID: 16927859
[TBL] [Abstract][Full Text] [Related]
6. The liver function profile in PCR-RNA Egyptian HCV-patients and normal controls.
Wahib AA; Seif El Nasr MS; Mangoud AM; El Shazly AM; Morsy AT
J Egypt Soc Parasitol; 2005 Aug; 35(2):451-66. PubMed ID: 16083059
[TBL] [Abstract][Full Text] [Related]
7. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF
Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268
[TBL] [Abstract][Full Text] [Related]
8. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
9. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy.
Tan L; Meng Y; Zeng T; Wang Q; Long T; Wu S; Guan X; Fu H; Zheng W; Tian Y; Chen J; Yu J; Wu Y; Li H; Cao L
Br J Biomed Sci; 2019 Jan; 76(1):24-28. PubMed ID: 30392460
[TBL] [Abstract][Full Text] [Related]
10. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C.
Shiha G; Seif S; Eldesoky A; Elbasiony M; Soliman R; Metwally A; Zalata K; Mikhail N
Hepatol Int; 2017 May; 11(3):286-291. PubMed ID: 28425016
[TBL] [Abstract][Full Text] [Related]
11. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters.
Fehr T; Riehle HM; Nigg L; Grüter E; Ammann P; Renner EL; Ambühl PM
Am J Kidney Dis; 2003 Jul; 42(1):193-201. PubMed ID: 12830472
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatic enzymes in the biochemical assessment of the severity of sickle cell anemia.
Oparinde DP; Oghagbon EK; Okesina AB; Olatunji PO; Ojuawo AO
Trop Gastroenterol; 2006; 27(3):118-21. PubMed ID: 17310554
[TBL] [Abstract][Full Text] [Related]
14. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
Reedy DW; Loo AT; Levine RA
Dig Dis Sci; 1998 Sep; 43(9):2156-9. PubMed ID: 9753286
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
16. [Plasma levels of folate and vitamin B(12) in patients with chronic liver disease].
Muro N; Bujanda L; Sarasqueta C; Gil I; Hijona E; Cosme A; Arenas J; Elosegui ME; Sarasola M; Calpasoro J; Arenas JI
Gastroenterol Hepatol; 2010 Apr; 33(4):280-7. PubMed ID: 20206409
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical changes of liver damage factors in the course of mononucleosis like syndrome caused by cytomegalovirus].
Janeczko J
Przegl Epidemiol; 2000; 54(3-4):325-32. PubMed ID: 11349595
[TBL] [Abstract][Full Text] [Related]
18. Serum enzyme levels in alcoholism and drug dependency.
Patel S; O'Gorman P
J Clin Pathol; 1975 May; 28(5):414-7. PubMed ID: 239023
[TBL] [Abstract][Full Text] [Related]
19. Serum enzyme tests in hepatosplenic schistosomiasis.
Mansour MM; Farid Z; Bassily S; Salah LH; Watten RH
Trans R Soc Trop Med Hyg; 1982; 76(1):109-11. PubMed ID: 6123167
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
